Drugs / Arylsulfatase A
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT00633139 | Jan 2007 → Nov 2008 | metachromatic leukodystrophy, late infantile form | Shire | Completed | Missed primary |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Arylsulfatase A | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00633139 ↗ |
| Modality | Protein / enzyme biologic | “intravenous (IV) recombinant human ASA” PMID 33332761 ↗ Dec 2020 |
| Route | Intravenous | “intravenous (IV) recombinant human ASA” PMID 33332761 ↗ Dec 2020 |